Leukemia & Lymphoma, Volume 50, Issue 5 (2009)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 50, Issue 5 (2009)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Volume 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article Commentary
Targeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphoma
Jia Ruan M.D., Ph.D. & John P. Leonard
Pages: 679-681
Published online: 21 Jul 2009
First Page PreviewforTargeting angiogenesis: a novel, rational therapeutic approach for non-Hodgkin lymphoma | Full Text | References | PDF (234.6 KB)
  • 53 Views
  • 6 CrossRef citations
  • 0Altmetric
Article Commentary
Dose intense therapy for relapsed lymphoproliferative disorders: the more things change, the more they are the same
Amir A. Toor
Pages: 682-683
Published online: 21 Jul 2009
CitationforDose intense therapy for relapsed lymphoproliferative disorders: the more things change, the more they are the same | Full Text | References | PDF (227.4 KB)
  • 8 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus-positive lymphomas: are we there yet?
Kimberley Jones & Maher K. Gandhi
Pages: 684-686
Published online: 21 Jul 2009
First Page PreviewforEpstein–Barr virus DNA as a biomarker for Epstein–Barr virus-positive lymphomas: are we there yet? | Full Text | References | PDF (232.8 KB)
  • 78 Views
  • 2 CrossRef citations
  • 0Altmetric
Article Commentary
Expansion of regulatory T cells in B chronic lymphocytic leukemia: enhanced ‘brakes’ on host immunity
Varda Deutsch, Chava Perry & Aaron Polliack
Pages: 687-688
Published online: 21 Jul 2009
CitationforExpansion of regulatory T cells in B chronic lymphocytic leukemia: enhanced ‘brakes’ on host immunity | Full Text | References | PDF (239.7 KB)
  • 78 Views
  • 12 CrossRef citations
  • 0Altmetric
Article Commentary
Overcoming glucocorticoid resistance: a new pathway from an ancient Chinese medicine?
Nancy Krett & Shuo Ma
Pages: 689-690
Published online: 21 Jul 2009
CitationforOvercoming glucocorticoid resistance: a new pathway from an ancient Chinese medicine? | Full Text | References | PDF (225.2 KB)
  • 91 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Myeloma antioxidant status: the good, the bad and the reactive
Christine M. Stellrecht & Varsha Gandhi
Pages: 691-693
Published online: 21 Jul 2009
First Page PreviewforMyeloma antioxidant status: the good, the bad and the reactive | Full Text | References | PDF (255.3 KB)
  • 57 Views
  • 4 CrossRef citations
  • 0Altmetric

Reviews

Review Article
Clinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia
Jacob P. Laubach, Constantine S. Mitsiades, Aldo M. Roccaro, Irene M. Ghobrial, Kenneth C. Anderson & Paul G. Richardson
Pages: 694-702
Published online: 21 Jul 2009
AbstractforClinical challenges associated with bortezomib therapy in multiple myeloma and Waldenströms Macroglobulinemia | Full Text | References | PDF (188 KB)
  • 146 Views
  • 28 CrossRef citations
  • 0Altmetric
Review Article
Invasive mold infections: recent advances in management approaches
Pranatharthi Chandrasekar MD
Pages: 703-715
Published online: 21 Jul 2009
AbstractforInvasive mold infections: recent advances in management approaches | Full Text | References | PDF (572.6 KB)
  • 289 Views
  • 25 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma – long-term results of a multicenter observation study
Oliver Weigert MD, Eckhart Weidmann, Rudolf Mueck, Martin Bentz, Christoph von Schilling, Robert Rohrberg, Kathleen Jentsch-Ullrich, Wolfgang Hiddemann & Martin Dreyling
Pages: 716-722
Published online: 21 Jul 2009
AbstractforA novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma – long-term results of a multicenter observation study | Full Text | References | PDF (200.1 KB)
  • 540 Views
  • 48 CrossRef citations
  • 0Altmetric
Article
Genetic polymorphism of the inhibitory IgG Fc receptor FcgammaRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab
Wen-Kai Weng & Ronald Levy
Pages: 723-727
Published online: 21 Jul 2009
AbstractforGenetic polymorphism of the inhibitory IgG Fc receptor FcgammaRIIb is not associated with clinical outcome in patients with follicular lymphoma treated with rituximab | Full Text | References | PDF (255.4 KB)
  • 173 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
A phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108
Alison T. Stopeck M.D., Joseph M. Unger, Lisa M. Rimsza, William T. Bellamy, Maria Iannone, Daniel O. Persky, Michael Leblanc, Richard I. Fisher & Thomas P. Miller
Pages: 728-735
Published online: 21 Jul 2009
AbstractforA phase II trial of single agent bevacizumab in patients with relapsed, aggressive non-Hodgkin lymphoma: Southwest oncology group study S0108 | Full Text | References | PDF (1 MB)
  • 222 Views
  • 66 CrossRef citations
  • 0Altmetric
Article
Lack of HER-2 gene amplification in non-Hodgkin lymphoma using chromogenic in situ hybridisation test
Sergio Szvalb, Moshe Stein, Anthony Gershuny, Eli Gez, Amram Hadary & Jamal Zidan MD
Pages: 736-740
Published online: 21 Jul 2009
AbstractforLack of HER-2 gene amplification in non-Hodgkin lymphoma using chromogenic in situ hybridisation test | Full Text | References | PDF (410.7 KB)
  • 46 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival
Thomas C. Shea MD, Anne W. Beaven, Dominic T. Moore, Jonathan S. Serody, Don A. Gabriel, Nelson Chao, Jon P. Gockerman, Reynaldo A. Garcia & David A. Rizzieri
Pages: 741-748
Published online: 21 Jul 2009
AbstractforSequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival | Full Text | References | PDF (247.4 KB)
  • 189 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Composite lymphoma with relapse of enteropathy-type T-cell lymphoma
Zunguo Du, Jieqing Chen, Xiaoyan Zhou, Taiming Zhang, Bobin Chen & Feng Tang MD, PhD
Pages: 749-756
Published online: 21 Jul 2009
AbstractforComposite lymphoma with relapse of enteropathy-type T-cell lymphoma | Full Text | References | PDF (1.8 MB)
  • 139 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma
Hyo Song Kim, Kyung Hee Kim, Kyoung Ha Kim, Myung Hee Chang, Sang Hoon Ji, Do Hyoung Lim, Kihyun Kim, Seok Jin Kim, Younghyeh Ko, Chang-Seok Ki MD, PhD, Sook Jung Jo, Jae Won Lee & Won Seog Kim MD, PhD
Pages: 757-763
Published online: 21 Jul 2009
AbstractforWhole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma | Full Text | References | PDF (678.2 KB)
  • 419 Views
  • 54 CrossRef citations
  • 0Altmetric
Article
Immunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis
Pia Raanani MD, Anat Gafter-Gvili, Mical Paul, Isaac Ben-Bassat, Leonard Leibovici & Ofer Shpilberg
Pages: 764-772
Published online: 21 Jul 2009
AbstractforImmunoglobulin prophylaxis in chronic lymphocytic leukemia and multiple myeloma: systematic review and meta-analysis | Full Text | References | PDF (821.3 KB)
  • 2183 Views
  • 96 CrossRef citations
  • 0Altmetric
Article
BCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia
Eloisa Jantus Lewintre PhD, Cristina Reinoso Martín, Carlos García Ballesteros, Jehzabel Pendas, Carmen Benet Campos, José Ramón Mayans Ferrer & Javier García-Conde
Pages: 773-780
Published online: 21 Jul 2009
AbstractforBCL6: somatic mutations and expression in early-stage chronic lymphocytic leukemia | Full Text | References | PDF (463.4 KB)
  • 574 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Factors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma
Luciano J. Costa MD, PhD, Shaji Kumar, Angela Dispenzieri, Suzanne E. Hayman, Francis K. Buadi, David Dingli, Mark R. Litzow, Morie A. Gertz & Martha Q. Lacy
Pages: 781-787
Published online: 21 Jul 2009
AbstractforFactors associated with favorable outcome after allogeneic hematopoietic stem cell transplantation for multiple myeloma | Full Text | References | PDF (321.8 KB)
  • 104 Views
  • 4 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia
Margot Jak, Margot Jak, Rogier Mous, Ester B. M. Remmerswaal, René Spijker, Annelieke Jaspers, Adriana Yagüe, Eric Eldering, René A. W. Van Lier & Marinus H. J. Van Oers
Pages: 788-801
Published online: 21 Jul 2009
AbstractforEnhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia | Full Text | References | PDF (1 MB)
  • 503 Views
  • 89 CrossRef citations
  • 0Altmetric
Article
Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma
Min Yang, Jia-Kun Shen, Jian Huang, Hua-Ping Du, Qiu-Ling Ma & Jie Jin MD, PhD
Pages: 802-808
Published online: 21 Jul 2009
AbstractforInterleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma | Full Text | References | PDF (1.1 MB)
  • 131 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Study of antioxidant levels in patients with multiple myeloma
Alpana Sharma, Manjul Tripathi, Abhigyan Satyam & Lalit Kumar
Pages: 809-815
Published online: 21 Jul 2009
AbstractforStudy of antioxidant levels in patients with multiple myeloma | Full Text | References | PDF (166.9 KB)
  • 271 Views
  • 58 CrossRef citations
  • 0Altmetric
Article
The Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1
Jürgen S. Scheele, Mateusz Kolanczyk, Melanie Gantert, Tomasz Zemojtel, Annette Dorn, David P. Sykes, Dietrich C. C. Möbest, Mark P. Kamps, Daniel Räpple & Marlena Duchniewicz
Pages: 816-828
Published online: 21 Jul 2009
AbstractforThe Spt-Ada-Gcn5-acetyltransferase complex interaction motif of E2a is essential for a subset of transcriptional and oncogenic properties of E2a-Pbx1 | Full Text | References | PDF (1.7 MB)
  • 130 Views
  • 8 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Infrequent occurrence of PIK3CA mutations in chronic lymphocytic leukemia
Millaray Marincevic, Gerard Tobin & Richard Rosenquist MD, PhD
Pages: 829-830
Published online: 21 Jul 2009
CitationforInfrequent occurrence of PIK3CA mutations in chronic lymphocytic leukemia | Full Text | References | PDF (132.2 KB)
  • 136 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement
Bachir Alobeid, Deborah W. Sevilla, Mahmoud B. El-Tamer, Vundavalli V. Murty, David G. Savage & Govind Bhagat
Pages: 831-833
Published online: 21 Jul 2009
First Page PreviewforAggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement | Full Text | References | PDF (438.7 KB)
  • 350 Views
  • 48 CrossRef citations
  • 0Altmetric
Letter
Detection of mutations in GATA1 gene using automated denaturing high-performance liquid chromatography and direct sequencing in children with Down syndrome
Marcia R. Amorim, Marcia R. Amorim, Alexandre B. C. Figueiredo, Alessandra Splendore, Isis Q. Magalhães, Maria S. Pombo-d´e-Oli˙veira, Bcsgail, Kênia B. El-Jaick, Maria Lydia D'andrea, Jozina Aquino, Dora Márcia Alencar, Silvia R. Brandalise, Lilian Burlemaqui, Teresa Cristina Cardoso, Eni Guimarães Carvalho, Virginia M. Coser, Imaruí Costa, Dolores Dorea, Mauricio Drumond, Venâncio Gomes Lopes, Núbia Mendonça, Maria Lucia M. Lee, Luis Fernando Lopes, Carmen M. Mendonça, Flávia Nogueira, Flávia Pimenta, Vitória P. Pinheiro, Denise Bousfield Da Silva, Elaine Sobral, Fernando R. Vargas & Fernando Werneck
Pages: 834-840
Published online: 21 Jul 2009
AbstractforDetection of mutations in GATA1 gene using automated denaturing high-performance liquid chromatography and direct sequencing in children with Down syndrome | Full Text | References | PDF (958.6 KB)
  • 118 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Platelet count is an independent prognostic factor in myelodysplastic syndromes considered as low risk by French–American–British and World Health Organisation classifications
Massimo Breccia MD, Gianna Maria D'Elia, Laura Cannella, Caterina Stefanizzi, Angelo Fama, Vincenzo Federico, Michelina Santopietro & Giuliana Alimena
Pages: 841-843
Published online: 21 Jul 2009
First Page PreviewforPlatelet count is an independent prognostic factor in myelodysplastic syndromes considered as low risk by French–American–British and World Health Organisation classifications | Full Text | References | PDF (136.2 KB)
  • 49 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Serum soluble tumor necrosis factor-related apoptosis-inducing ligand level after allogeneic hematopoietic cell transplantation
Tomomi Toubai MD, PhD, Yusuke Shono, Somako Tone, Makoto Ibata, Naoko Kato, Chelsea Malter, Kathleen P. Lowler, Shuichi Ota, Junji Tanaka, Masahiro Asaka & Masahiro Imamura
Pages: 844-847
Published online: 21 Jul 2009
First Page PreviewforSerum soluble tumor necrosis factor-related apoptosis-inducing ligand level after allogeneic hematopoietic cell transplantation | Full Text | References | PDF (211.4 KB)
  • 37 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Dasatinib overcomes imatinib and nilotinib failure in Philadelphia chromosome positive chronic myeloid leukemia with different mechanisms of resistance
Laura Cannella MD, Massimo Breccia, Caterina Stefanizzi, Laura Napoleone, Michela Santopietro & Giuliana Alimena
Pages: 848-850
Published online: 21 Jul 2009
First Page PreviewforDasatinib overcomes imatinib and nilotinib failure in Philadelphia chromosome positive chronic myeloid leukemia with different mechanisms of resistance | Full Text | References | PDF (136.1 KB)
  • 96 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Molecular stratification of patients with normal karyotype acute myeloid leukemia based on initial assessment of FLT3-internal tandem duplication status at first complete remission
Bruno C. Medeiros, Jason Gotlib & James Zehnder
Pages: 851-853
Published online: 21 Jul 2009
First Page PreviewforMolecular stratification of patients with normal karyotype acute myeloid leukemia based on initial assessment of FLT3-internal tandem duplication status at first complete remission | Full Text | References | PDF (138.7 KB)
  • 41 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Familial occurrence of chronic myeloid leukemia
Giovanni Caocci, Sandra Atzeni, Adriana Vacca, Nicola Orrù, Antonio Ledda & Giorgio La Nasa
Pages: 854-856
Published online: 21 Jul 2009
First Page PreviewforFamilial occurrence of chronic myeloid leukemia | Full Text | References | PDF (136.4 KB)
  • 114 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Epstein-Barr virus-positive lymphoma after alemtuzumab therapy for B-cell chronic lymphocytic leukemia
Emanuele Ammatuna MD, PhD, Chiara Sarlo, Licia Ottaviani, Micol Quaresima, Francesco Buccisano, Selenia Campagna, Maria Ilaria Del Principe, Gottardo De Angelis, Lucia Anemona, Svitlana Gumenyuk, Sergio Amadori & Adriano Venditti
Pages: 857-858
Published online: 21 Jul 2009
CitationforEpstein-Barr virus-positive lymphoma after alemtuzumab therapy for B-cell chronic lymphocytic leukemia | Full Text | References | PDF (231.2 KB)
  • 71 Views
  • 2 CrossRef citations
  • 0Altmetric

Correspondence

Fluorescence in situ hybridisation in chronic lymphocytic leukemia in Hong Kong Chinese
K. F. Wong, Lisa L. P. Siu & W. S. Wong
Pages: 859-860
Published online: 21 Jul 2009
CitationforFluorescence in situ hybridisation in chronic lymphocytic leukemia in Hong Kong Chinese | Full Text | References | PDF (182.5 KB)
  • 38 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Direct and indirect costs for patients with myeloproliferative neoplasms
Jingbo Yu et al.
Article | Published online: 27 Apr 2024
Open Access
Targets and treatments in primary CNS lymphoma
Christina von Roemeling et al.
Review Article | Published online: 24 Apr 2024
Open Access
Challenges in management of older patients with chronic myeloid leukemia
Jessica M. Stempel et al.
Review Article | Published online: 23 Apr 2024
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr et al.
Article | Published online: 23 Apr 2024
Open Access
View all latest articles